The expression of anamorsin in diffuse large B cell lymphoma: possible prognostic biomarker for low IPI patients.

Abstract

Anamorsin is a cell-death-defying factor, which was originally isolated as a molecule that conferred resistance to apoptosis induced by growth factor starvation. In order to evaluate anamorsin expression levels in malignant lymphoma, we immunostained paraffin-embedded sections with anti-anamorsin monoclonal antibodies. About 40% (89/234) of sections from… (More)
DOI: 10.1080/10428190701713697

Topics

Cite this paper

@article{Shizusawa2008TheEO, title={The expression of anamorsin in diffuse large B cell lymphoma: possible prognostic biomarker for low IPI patients.}, author={Takae Shizusawa and Hirohiko Shibayama and Shinsuke Murata and Yuri Saitoh and Yuna Sugimoto and Itaru Matsumura and Hiroyasu Ogawa and H. Sugiyama and Shirou Fukuhara and Masayuki Hino and Akihisa Kanamaru and Amane Yamauchi and Katsuyuki Aozasa and Yuzuru Kanakura}, journal={Leukemia & lymphoma}, year={2008}, volume={49 1}, pages={113-21} }